ASCO® 2024 Insights: "Systemic Treatments in Favorable and Very Favorable Risk mRCC - Real-World Evidence From the IMDC"

Login

Password

Forgot your password?

Join VuMedi

Select specialty

First name

Last name

Choose Password

About Us
Careers
Partner with us
F.A.Q
Contact us
Terms & conditions
Privacy policy

Playback speed

10 seconds

This video is featured in the 2024 ASCO® Annual Meeting Insights Hub

ASCO® 2024 Insights: "Systemic Treatments in Favorable and Very Favorable Risk mRCC - Real-World Evidence From the IMDC"

By 2024 ASCO® Annual Meeting Insights Hub FEATURING Martin Zarba

244 views

June 7, 2024

Comments 0

Hypothetical Patient Case: 1L Advanced Renal Cell Carcinoma and Qual…

Feat. R. Alter, A. Rezazadeh

Hypothetical Patient Case: RAI-R Metastatic Differentiated Thyroid C…

Feat. R. Alter, R. Shameem

2024 ASCO® Annual Meeting Insights Hub: GU Videos

ASCO® 2024 Insights: "Landscape Analysis & Oncologic Outcomes in Adv…

2024 ASCO® Annual Meeting Insights Hub

T. Stewart

11 views

1 month ago

ASCO® 2024 Prostate Cancer Take-Home Messages

2024 ASCO® Annual Meeting Insights Hub

E. Efstathiou

606 views

3 months ago

ASCO® 2024 Summary: "Current Updates in RCC - Clinical Implications …

2024 ASCO® Annual Meeting Insights Hub

K. Mittal

364 views

4 months ago

View All

APCCC 2026

Fri, Feb 27, 2026

RENALC-BLADDR-PROSCA 2024

RENALC 2024 - Hybrid Global Forum on GU Oncology

Tue, Nov 26, 2024

See 1 other

RENALC-BLADDR-PROSCA 2024

PROSCA 2024 - Hybrid Global Forum on GU Oncology

Thu, Nov 28, 2024

Bladder Cancer Highlights From ASCO® 2024

2024 ASCO® Annual Meeting Insights Hub

G. Sonpavde

1.4K views

5 months ago

Surgical Management of High-Risk and Locally Advanced Prostate Cancer

Yale Cancer Center

I. Kim

432 views

1 month ago

Recent GU Developments and Their Clinical Implications

Insights from 2024 ASCO® GU Annual Meeting

T. Powles, B. Rini

1.5K views

8 months ago

Clinical Highlights From AACR 2024: Trials Evaluating Selected New T…

AdventHealth

G. Sonpavde

1.9K views

7 months ago

ASCO® GU 2024 Summary: "Important Prostate Cancer Take-Home Messages"

Insights from 2024 ASCO® GU Annual Meeting

E. Efstathiou

2.6K views

9 months ago

ESMO 2024 Summary: GU Practice-Changing Trial Results of PEACE-3 (mC…

2024 ESMO Annual Meeting Insights Hub

R. Dreicer

276 views

1 month ago

New

Visible vs. Invisible Cancers - The Genomics and Natural History

Laurence Klotz

178 views

2 weeks ago

Hyperprogression in Cancer Treated With Immunotherapy

Northwestern Medicine Oncology and Hematology

Y. Chae

1.2K views

7 months ago

New

Enhanced Diagnostics in Prostate Cancer: PSA and Beyond in 2024

Penn Medicine Abramson Cancer Center

D. Lee

194 views

1 week ago

ASCO® 2024 Summary: "Current Updates in RCC - Clinical Implications …

2024 ASCO® Annual Meeting Insights Hub

K. Mittal

364 views

4 months ago

Testosterone Suppression and Recovery in Patients With Advanced Pros…

Benjamin L. Maughan

661 views

5 months ago

New

ESMO 2024 Summary: Developmental Therapeutics Highlights

2024 ESMO Annual Meeting Insights Hub

G. Sonpavde

236 views

3 weeks ago

New

Review of mCRPC Updates From ESMO 2024

The View on GU | with Lalani & Wallis

A. A. Lalani, C. Wallis

71 views

3 weeks ago

New

Treatment (De)Intensification in RCC

International Urology Cancer Summit - IUCS

S. Kumar Pal

152 views

4 weeks ago

ASCO® 2024 Insights: "Evaluation of Persistence and Adherence for Or…

2024 ASCO® Annual Meeting Insights Hub

J. Hafron

643 views

5 months ago

No Role to Continue ICI Beyond Progression: CONTACT-03 & TiNivo-2 Ph…

Dana-Farber Cancer Institute

B. McGregor

133 views

1 month ago

New

Evolving Strategies in First and Second-Line Treatment for mCRPC

International Urology Cancer Summit - IUCS

N. Agarwal

131 views

4 weeks ago

Best of Bladder Cancer and RCC From ESMO 2023 and GU ASCO 2024

Total Health

M. Reimers

529 views

8 months ago

ESMO 2024 Summary: Important GU Trials - ETER100 (RCC), TACITO (mRCC…

2024 ESMO Annual Meeting Insights Hub

C. Porta

174 views

1 month ago

ESMO 2024 Summary: Bladder and RCC Highlights

2024 ESMO Annual Meeting Insights Hub

K. Tawagi, N. Reizine

108 views

1 month ago

AUTOPLAY

Login

Login

Join VuMedi

ASCO® 2024 Insights: "Systemic Treatments in Favorable and Very Favorable Risk mRCC - Real-World Evidence From the IMDC"

Hypothetical Patient Case: 1L Advanced Renal Cell Carcinoma and Qual…

Hypothetical Patient Case: RAI-R Metastatic Differentiated Thyroid C…

2024 ASCO® Annual Meeting Insights Hub: GU Videos

ASCO® 2024 Insights: "Landscape Analysis & Oncologic Outcomes in Adv…

ASCO® 2024 Prostate Cancer Take-Home Messages

ASCO® 2024 Summary: "Current Updates in RCC - Clinical Implications …

Recommended

APCCC 2026

RENALC 2024 - Hybrid Global Forum on GU Oncology

PROSCA 2024 - Hybrid Global Forum on GU Oncology

Bladder Cancer Highlights From ASCO® 2024

Surgical Management of High-Risk and Locally Advanced Prostate Cancer

Recent GU Developments and Their Clinical Implications

Clinical Highlights From AACR 2024: Trials Evaluating Selected New T…

ASCO® GU 2024 Summary: "Important Prostate Cancer Take-Home Messages"

ESMO 2024 Summary: GU Practice-Changing Trial Results of PEACE-3 (mC…

Visible vs. Invisible Cancers - The Genomics and Natural History

Hyperprogression in Cancer Treated With Immunotherapy

Enhanced Diagnostics in Prostate Cancer: PSA and Beyond in 2024

ASCO® 2024 Summary: "Current Updates in RCC - Clinical Implications …

Testosterone Suppression and Recovery in Patients With Advanced Pros…

ESMO 2024 Summary: Developmental Therapeutics Highlights

Review of mCRPC Updates From ESMO 2024

Treatment (De)Intensification in RCC

ASCO® 2024 Insights: "Evaluation of Persistence and Adherence for Or…

No Role to Continue ICI Beyond Progression: CONTACT-03 & TiNivo-2 Ph…

Evolving Strategies in First and Second-Line Treatment for mCRPC

Best of Bladder Cancer and RCC From ESMO 2023 and GU ASCO 2024

ESMO 2024 Summary: Important GU Trials - ETER100 (RCC), TACITO (mRCC…

ESMO 2024 Summary: Bladder and RCC Highlights